Omeros Corp (OMER) stock
OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
$17.49−0.50 (-2.78%)
Close on Nov 13, 2026Market cap $1.27BP/E –Yield –
Omeros total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Omeros's total debt was $2.56M at Mar 31, 2019. For fiscal 2018 it was $889.00K, down 98.9% from the year before. The highest annual figure on record is $84.61M in fiscal 2017.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $889.00K | -98.9% |
| FY2017 | Dec 31, 2017 | $84.61M | +6.1% |
| FY2016 | Dec 31, 2016 | $79.71M | +59.9% |
| FY2015 | Dec 31, 2015 | $49.84M | +53.6% |
| FY2014 | Dec 31, 2014 | $32.45M | +58.3% |
| FY2013 | Dec 31, 2013 | $20.50M | +2.0% |
| FY2012 | Dec 31, 2012 | $20.10M | +3.4% |
| FY2011 | Dec 31, 2011 | $19.45M | +97.2% |
| FY2010 | Dec 31, 2010 | $9.86M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2019 | Mar 31, 2019 | $2.56M | -97.0% |
| Q4 FY2018 | Dec 31, 2018 | $889.00K | -98.9% |
| Q3 FY2018 | Sep 30, 2018 | $132.26M | +59.1% |
| Q2 FY2018 | Jun 30, 2018 | $130.36M | +59.4% |
| Q1 FY2018 | Mar 31, 2018 | $85.55M | +6.0% |
| Q4 FY2017 | Dec 31, 2017 | $84.61M | +6.1% |
| Q3 FY2017 | Sep 30, 2017 | $83.15M | +18.0% |
| Q2 FY2017 | Jun 30, 2017 | $81.76M | +16.8% |
| Q1 FY2017 | Mar 31, 2017 | $80.73M | – |
| Q4 FY2016 | Dec 31, 2016 | $79.71M | – |
| Q3 FY2016 | Sep 30, 2016 | $70.48M | – |
| Q2 FY2016 | Jun 30, 2016 | $70.03M | – |
See a number that looks wrong?